Clinical Trials Browser

Phase 2 × Vorinostat × Gastrointestinal × Clear all

Squamous Cell Carcinoma of Head and Neck, Anus Neoplasms, Carcinoma, Squamous Cell, Uterine Cervical Neoplasms, Penile Neoplasms, Vulvar Neoplasms, Neoplasms, Squamous Cell

NCT02316340 2024-01-05

Vorinostat Plus Hydroxychloroquine Versus Regorafenib in Colorectal Cancer

Phase 2 Completed

42 enrolled 8 charts

Gastrointestinal

Colorectal Neoplasms

NCT00126451 2017-04-10

A Clinical Trial of Oral Suberoylanilide Hydroxamic Acid (SAHA) in Patients With Relapsed or Refractory Breast, Colorectal and Non-Small Cell Lung Cancer (0683-011)(TERMINATED)

Phase 2 Terminated

16 enrolled

BreastGastrointestinalThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Colorectal Neoplasms

NCT00942266 2014-06-23

Vorinostat, Fluorouracil, and Leucovorin Calcium in Treating Patients With Metastatic Colorectal Cancer That Has Not Responded to Previous Treatment

Phase 2 Completed

58 enrolled 14 charts

Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms

Clinical Trials

PEVOsq

Vorinostat Plus Hydroxychloroquine Versus Regorafenib in Colorectal Cancer

A Clinical Trial of Oral Suberoylanilide Hydroxamic Acid (SAHA) in Patients With Relapsed or Refractory Breast, Colorectal and Non-Small Cell Lung Cancer (0683-011)(TERMINATED)

Vorinostat, Fluorouracil, and Leucovorin Calcium in Treating Patients With Metastatic Colorectal Cancer That Has Not Responded to Previous Treatment